CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: As expected, CML CD34+ cells cultured in the presence of 100 nM FICZ proliferated significantly less than control cultures in the presence of DMSO (0.01%) as noted by the 3-fold decrease of the number of CD34+ cells at day 7 (Fig 5).